Thursday 22 |  September 2016

 
   LSBC EVENTS

LifeSciences BC McCarthy Spotlight Speaking Series on "Leading Small Teams"

September 22, 2016

 


LifeSciences BC
is pleased to feature the Sauder School of Business, STEMCELL Technologies Inc., AbCellera at our McCarthy Spotlight Speaking Event on
Leading Small Teams  

Event Topic: How to successfully manage and lead small teams or groups, whether in the context of a biotech start-up or within a larger life sciences organization.

Sub-Topics Covered:

*    Theoretical approaches and key principles of leadership from a corporate perspective; presentation by Dr. Michael Daniels, Assistant Professor, Organizational Behaviour & Human Resources, Sauder School of Business, UBC.
*    How to successfully choose your business leaders, how to assign roles for key individuals within your life science business and how to successfully transition from founder and scientist to CEO; presentation by Carl Hansen, CEO of AbCellera;
*    Successful leadership of (small) teams/groups at any level within a large life science enterprise; presentation by Nina Bagri, Associate Director - US Sales Cell Culture Products STEMCELL Technologies Inc.
 
Event Details

Date: September 22, 2016
Time: 4:30 - 7:30 PM
Location: Terminal City Club, 837 West Hastings, Vancouver
For Information Contact:
Sarah Wuertz, Manager, Operations & Events
LifeSciences BC
Phone: 604-669-9909 Ext. 104

 

Access to Innovation
November 2 & 3, 2016
Vancouver, BC
 

Hosted for its second year, LifeSciences BC's Access to Innovation Conference will bring together health and life sciences stakeholders to present, discuss and deliver meaningful ways to culitivate collaboration, develop and deliver innovation, while improving outcomes and saving healthcare cost.
 
Keynote Speakers: Hon. Dr. Andrew Wilkinson, Minister of Advanced Education & Hon. Amrik Virk, Minister of Technology, Innovation & Citizens' Services

Confirmed Presenters: Dr. Jane Aubin, Dr. Robert McMaster, Dr. Brendan Byrne, Dr. David Castle, Dr. Heather Davidson, Dr. Bettina Hamelin, Dr. Simon Sutcliffe, Dr. Gavin Stuart, Dr. Sue Collier and Dr. Leslie Alexander, CEO & President, Life Sciences Washington 

 

  MEMBER NEWS
BIOLUX RESEARCH ANNOUNCES IRISH DISTRIBUTION AGREEMENT WITH PROMED FOR ORTHOPULSE®

VANCOUVER, CANADA / September 16, 2016 - Biolux Research, designer and developer of Light Accelerated Orthodontics™ technology and products, is excited to announce it has reached agreement with Promed, for developing the Irish market.

Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock 

VANCOUVER, British Columbia - Sept. 19, 2016 (GLOBE NEWSWIRE) - Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today announced that it intends to offer and sell, subject to market and other conditions, an underwritten public offering of its common stock.

Aquinox Prices Public Offering of Common Stock

VANCOUVER, British Columbia, Sept. 19, 2016 (GLOBE NEWSWIRE) - Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today announced the pricing of an underwritten public offering of 5,350,000 shares of its common stock at a price to the public of $12.25 per share.

Conquer Mobile and University of British Columbia Collaborate to Create Mobile Game for Large Scale Parkinson's Research Study

A new, large-scale Parkinson's research study, collecting data through mobile game mechanics, will be announced at the World Parkinson's Congress this week.

  INDUSTRY NEWS
FDA launches naloxone app competition to combat opioid overdose deaths

September 21st, 2016 | By: Katie Bell |The FDA announced that it is launching a public contest in which participants are being asked to create a mobile phone app that connects opioid users who are experiencing an overdose, with nearby carriers of the prescription opioid antidote naloxone, "thereby increasing the likelihood of timely administration and overdose reversal."
Physician Views: FirstWord is polling neurologists in response to positive data for Novartis' siponimod in secondary progressive MS

September 21st, 2016 | By: Simon King | Focus has sharpened on Novartis' siponimod (also known as BAF312) since confirmation last month of Phase III success in secondary progressive multiple sclerosis (SPMS).

UN signs historic declaration to fight AMR

September 22, 2016 | By: Selina McKee | A historic declaration to combat antimicrobial resistance has been signed by 193 countries at a United Nations General Assembly.
Star-studded syndicate pumps $33M into preclinical DNA repair cancer startup 

September 21, 2016 |By: Nick Paul Taylor | SV Life Sciences has joined with the VC wings of AbbVie ($ABBV) and Merck KGaA to funnel $33.2 million (€29.8 million) into a DNA damage repair (DDR) startup.

  IN THIS ISSUE
PLATINUM SPONSORS
GOLD SPONSORS

SILVER SPONSORS

BRONZE SPONSORS

MSFHR
  HEALTH NEWS
Zuckerberg and Chan aim to tackle all disease by 2100

September 21, 2016 | By Leo Kelion, Technology desk editor, BBC NEWS | At a press conference in San Francisco, they said their ultimate goal was to "cure, prevent or manage all diseases by the end of the century".

   Q&A: Can Facebook billions stop disease? This neuroscientist aims to find out

September 21, 2016 | By Jocelyn Kaiser | It's proving to be a banner year for science philanthropy, with the likes of former New York City Mayor Michael Bloomberg and Napster Co-Founder Sean Parker giving hundreds of millions of dollars to medical research.

Cognitive Offloading: Memory and Internet

September 2016 | By: Jennifer Delgado,  Psychology Spot | Internet is part of our lives. Undoubtedly, it useful in several areas and permits to save valuable time, stay in touch with anyone anywhere in the world and, of course, keeps us informed. But everything has a price, and Internet is no exception and, if we are not careful, the excessive use of the network might cause some cognitive problems that we would never have.

Stem cell 'heart patch' moves closer to clinic

September 21, 2016  | By Terry Devitt, University of Wisconsin, Madison | The promise of stem cells to treat cardiovascular disease may soon be a step closer to clinical application as scientists from three institutions seek to perfect and test three-dimensional "heart patches" in a large animal model - the last big hurdle before trials in human patients.

    UPCOMING OPPORTUNITIES 
Free Webcast of "Demystifying the US Healthcare and Life Sciences Market
September 30, 2016 

In collaboration with MaRS and in partnership with the Trade Commissioner Service (TCS) of Global Affairs Canada, EDC invites you to a Life Sciences and Health Care webcast, live streamed from Toronto, Ontario. 

Date: September 30, 2016  
Time: 09:00 AM EDT  
Agenda 
PANEL DISCUSSION & Q&A  
9:00 AM - 11:00 AM

Facilitated by Dr. Jason Field, Executive Director of Life Sciences Ontario, the panel discussion will focus on the following topic: "Demystifying the US Healthcare and Life Sciences Market". The panel members will provide insight into some of the challenges and opportunities faced by Canadian companies in the Life Sciences and Healthcare sectors that are targeting the US market, including discussions on the regulatory environment and reimbursement.

PANELISTS  
*Pravin Chaturvedi, President & Chief Executive Officer of Pivot Pharmaceuticals, Inc. 
*Jessica Holmes, Executive Director of Reimbursement of Argenta Advisors, Inc. 
*Antonio Lopes, Global Accounts Director, Export Development Canada 
*Matt Pasiuk, Canadian Trade Commissioner in San Francisco for Foreign Affairs and Trade Development Canada 
*Kevin Talbot, Co-Founder & Managing Partner of Relay Ventures 
*Lawrence Vernaglia, Partner & Chair, Health Care Practice Group, Foley and Lardner, Venture Partner at Converge Venture Partners

For more information please click here  
  JOB LINKS
Life Science Career Opportunities
   NEW COST SAVINGS FOR MEMBERS
Did you know about our Business Solutions Program? Through our vendor partners, LifeSciences BC members can benefit from significant savings on a number of business services. For the full list of cost savings for members, please see: http://www.lifesciencesbc.ca/membership/members-lsbc-business-solutions-program/
Introducing the UPS® Members Benefit Program for Life Sciences BC Members
 
Take advantage of the UPS Members Benefit Program and save on a variety of UPS services! You'll receive 30% off small package shipments within Canada, to the U.S. and to worldwide destinations, 25% off imports into Canada, discounts starting at 70% off freight shipments and more.  
  
Save on office supplies and more with Grand & Toy

Through your Life Sciences BC membership, you can save 10%-20% off the web price of wide range of office supplies from Grand & Toy! Plus, there is no charge for next-business-day delivery on orders over $50 to most Canadian locations. (Some conditions apply.) 
 
Corporate discounts & group rates at The Listel Hotel

The Listel Hotel, a four star boutique hotel, is known for its enthusiastic service and commitment to high design and guest comfort. This intimate Robson street hotel boasts a perfect location with an award-winning restaurant Forage and gastro-pub Timber.
 
Suite 580 1285 West Broadway, 
Vancouver, BC V6H 3X8
604-669-9909
info@lifesciencesbc.ca